No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Adjuvant ibandronate does not improve survival in postmenopausal patients with ER⁺ breast cancer

byTeddy Guo

October 4, 2022

in StudyGraphics

Reading Time: 1 min read

The Scan by 2 Minute Medicine®: A Misconception about Miscarriage, Scandal and ADHD, 10000 Steps per Day and Marijuana During Pregnancy!

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Statins do not increase breast cancer risk in postmenopausal women

April 7, 2026

Stochastic resonance stimulation may decrease apnea of prematurity

Weekly Rewinds

2 Minute Medicine Rewind April 6, 2026

April 6, 2026

Radiation plus hormone therapy may improve prostate cancer survival

Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants

Cefepime/enmetazobactam superior to piperacillin/tazobactam for the treatment of complicated urinary tract infections and acute pyelonephritis

No obesity paradox found between BMI, stroke, and death

Asundexian does not reduce the risk of recurrent strokes after non-cardioembolic ischemic stroke

Provision of medically-tailored meals linked with lower admissions and medical spending

The Effect of High-Polyphenol Mediterranean Diet on Visceral Adiposity

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports